CXCR4 and non-Hodgkin lymphoma: Blocking CXCR4 with small molecule (Plerixafor/Mozobil) is approved for CD34+ heme progenitors harvest prior to haematopoietic stem cell transplantation in multiple myeloma (MM) and NHL therapy27.